Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Caitlin C. Chrystoja"'
Publikováno v:
Surgical Innovation. 29:249-257
Background: The transition from surgical residency to independent practice is a challenging period that has not been well studied. Methods: An email invitation to complete a 55-item survey and the Maslach Burnout Inventory–Human Services Survey (MB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90f2f57f8907308c39f1aa1ce5456295
https://doi.org/10.1177/15533506211039682
https://doi.org/10.1177/15533506211039682
Autor:
Saerom Youn, Nancy N. Baxter, Harindra C. Wijeysundera, George Tomlinson, Chaim M. Bell, David R. Urbach, Anna R. Gagliardi, Shannon Wong, Julie Takata, Caitlin C. Chrystoja, Lakhbir Sandhu
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Surgery
BMC Surgery
Objective: To estimate the bias associated with specific nonrandomized study attributes among studies comparing transcatheter aortic valve implantation with surgical aortic valve replacement for the treatment of severe aortic stenosis.Data sources an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c496fdf59f8cd1a7fb8c9793c0a7eda
https://doi.org/10.1186/s12893-021-01278-0
https://doi.org/10.1186/s12893-021-01278-0
Autor:
Audrey Laporte, Julie Takata, David R. Urbach, Nicholas E. Diamant, George Tomlinson, Wayne Deitel, Paul Kortan, Caitlin C. Chrystoja, Gail Darling
Publikováno v:
American Journal of Gastroenterology. 111:1536-1545
Achalasia is a chronic, progressive, and incurable esophageal motility disease. There is clinical uncertainty about which treatment should be recommended as first-line therapy. Our objective was to evaluate the effectiveness of pneumatic dilation com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6289c3dfa76604b1e46dfdf8881755
https://doi.org/10.1038/ajg.2016.402
https://doi.org/10.1038/ajg.2016.402
Autor:
Rafael Molina, Randy Haun, Felix Rückert, Randall Brand, Eleftherios P Diamandis, Caitlin C Chrystoja
Publikováno v:
Clinical Chemistry. 59:41-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21aebad074f7a8e660608284398b429f
https://doi.org/10.1373/clinchem.2012.196642
https://doi.org/10.1373/clinchem.2012.196642
Publikováno v:
Clinical chemistry. 60(5)
BACKGROUND Extraordinary technological advances and decreases in the cost of DNA sequencing have made the possibility of whole genome sequencing (WGS) as a highly accessible clinical test for numerous indications feasible. There have been many recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2061b4ac04adc9cd5e91776c5c5c88e2
https://pubmed.ncbi.nlm.nih.gov/24227285
https://pubmed.ncbi.nlm.nih.gov/24227285
Autor:
Apostolos Dimitromanolakis, Randall E. Brand, Caitlin C. Chrystoja, Ioannis Prassas, Eleftherios P. Diamandis, Sofia Farkona, Vathany Kulasingam, Felix Leung, Davor Brinc, Ivan M. Blasutig
Publikováno v:
Clinical chemistry. 60(2)
BACKGROUND By using proteomics and bioinformatics, we have previously identified a group of highly pancreas-specific proteins as candidate pancreatic ductal adenocarcinoma (PDAC) biomarkers. With the use of commercially available ELISAs, the performa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc891b650e615e316462feb67bd6341
https://pubmed.ncbi.nlm.nih.gov/24097894
https://pubmed.ncbi.nlm.nih.gov/24097894
Autor:
Ivan M. Blasutig, Hari Kosanam, Felix Rückert, Alison Chan, Ioannis Prassas, Ireena Soleas, Masato Maekawa, Eleftherios P. Diamandis, Robert Gruetzmann, Christian Pilarsky, Caitlin C. Chrystoja, Randall E. Brand, Apostolos Dimitromanolakis
Publikováno v:
Molecularcellular proteomics : MCP. 12(10)
In pancreatic cancer, the incidence and mortality curves coincide. One major reason for this high mortality rate in pancreatic ductal adenocarcinoma (PDAC) patients is the dearth of effective diagnostic, prognostic, and disease-monitoring biomarkers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abfee137e4da194515c4371b85840345
https://pubmed.ncbi.nlm.nih.gov/23798558
https://pubmed.ncbi.nlm.nih.gov/23798558
Autor:
Lisa Lix, Marko Simunovic, Rinku Sutradhar, Joshua K. Ramjist, David R. Urbach, Nancy N. Baxter, Caitlin C. Chrystoja
Publikováno v:
Journal of the American College of Surgeons. 223:S122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b288f4d2261d54ed39ef5675a2a07a35
https://doi.org/10.1016/j.jamcollsurg.2016.06.254
https://doi.org/10.1016/j.jamcollsurg.2016.06.254
Autor:
Caitlin C. Chrystoja, Ioannis Prassas, Eleftherios P. Diamandis, Antoninus Soosaipillai, Shalini Makawita, Hari Kosanam, Ivan M. Blasutig, Alison Chan, Apostolos Dimitromanolakis
Publikováno v:
Diagnosis.
Pancreatic cancer is a significant cause of cancer mortality. The high mortality rate of this disease is associated with the complete lack of early clinical symptoms. Moreover, existing tumor markers (e.g., CA19-9) are not sufficiently sensitive and/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a63cd35dc75d061ae0b46f4a252a05c
https://doi.org/10.1158/1538-7445.panca2012-a3
https://doi.org/10.1158/1538-7445.panca2012-a3
Publikováno v:
BMC Medicine
BMC Medicine, Vol 10, Iss 1, p 39 (2012)
BMC Medicine, Vol 10, Iss 1, p 39 (2012)
Background There is an important need for the identification of novel serological biomarkers for the early detection of cancer. Current biomarkers suffer from a lack of tissue specificity, rendering them vulnerable to non-disease-specific increases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c994fe86ccaeafe973f4d4604cf52b3
https://doi.org/10.1186/1741-7015-10-39
https://doi.org/10.1186/1741-7015-10-39